ASPG and acute lymphoblastic leukemia: Taken together, these findings suggest that apigenin enhances the therapeutic potential of L-asparaginase in T-ALL cells by acting on complementary pathways involving cell-cycle arrest and mitochondrial-mediated apoptosis.